REFERENCE
Ikeda S, Sakamaki H, Yajima S, Ikegami N.Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur, an oral fluoropyrimidine derivative, in patients with non-small-cell lung cancer in Japan. Value in Health 9: 106 (plus poster) abstr. PCN8, No. 3, May-Jun 2006
Rights and permissions
About this article
Cite this article
Tegafur/uracil cost effective for patients with NSCLC. Pharmacoecon. Outcomes News 507, 8 (2006). https://doi.org/10.2165/00151234-200605070-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605070-00014